Skip to main content

EVR 75 Pill - white round, 9mm

Pill with imprint EVR 75 is White, Round and has been identified as Everolimus 0.75 mg. It is supplied by Ascend Laboratories LLC.

Everolimus is used in the treatment of Neuroendocrine Carcinoma; Breast Cancer; Organ Transplant, Rejection Prophylaxis; Renal Angiomyolipoma; Pancreatic Cancer and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 0.75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for EVR 75

Everolimus 0.75 mg EVR 75

Everolimus

Imprint
EVR 75
Strength
0.75 mg
Color
White
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
MTOR inhibitors, Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ascend Laboratories LLC
Manufacturer
Alkem Laboratories Limited
National Drug Code (NDC)
67877-0720
Inactive Ingredients
butylated hydroxytoluene, lactose monohydrate, hypromelloses, lactose anhydrous, crospovidone, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "EVR 75"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.